An Overview on Methods, Evidence, and Study Quality of Health Economic Evaluation Studies for Independently Usable Digital Health Apps: Rapid Review
Ein Überblick über Methoden, Evidenz und Studienqualität von gesundheitsökonomischen Evaluationsstudien für unabhängig nutzbare digitale Gesundheits-Apps: Rapid Review
Journal of Medical Internet Research · 19.08.2025 · 27 · e68349-e68349
DOI: 10.2196/68349 ↗Auf einen Blick
Der Rapid Review fasst 7 gesundheitsökonomische Evaluationsstudien zu unabhängig nutzbaren DiHA zusammen. Vier Studien kamen zu dem Ergebnis, dass die App kosteneffektiv war.
Fragestellung
Welche ökonomische Evidenz, Methoden und Studienqualität liegen zu unabhängig nutzbaren digitalen Gesundheits-Apps für Patient:innen vor?
Methode
Systematische Suche in 4 Datenbanken und per Handsearch; 7 vollständige gesundheitsökonomische EEs wurden narrativ synthetisiert und mit RoB 2, CHEC und CHEERS bewertet.
Ergebnisse
7 Studien; alle nutzten Cost-Utility-Analysen. Die meisten basierten auf RCTs (n=5); Standardversorgung war der häufigste Vergleich (n=5). Der ICER wurde am häufigsten berichtet (n=4).
Einschränkungen
Mehr als die Hälfte der zugrunde liegenden RCTs hatte ein hohes Verzerrungsrisiko. Die Review fokussierte indikationsspezifische Apps und könnte breitere Anwendungen verfehlt haben.
Schlussfolgerung der Autor:innen
DiHA können kosteneffektiv sein, doch gesundheitsökonomische Evaluierungen werden noch nicht routinemäßig eingesetzt. Bessere Berichte zu RCT-Ergebnissen und konsistentere Modellierung sind nötig.
Kernaussagen
- 7 gesundheitsökonomische EEs eingeschlossen
- 4 Studien berichteten Kosteneffektivität
- Mehr als die Hälfte der RCTs mit hohem RoB
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medical Internet Research, online erschienen am 19.08.2025. Verfasst von Valerie Anne Alber und 5 weiteren Autor:innen. Beteiligte Einrichtung: Perfood GmbH, Lübeck, Germany. Hauptthemen laut MEDLINE: Mobile Applications, Digital Health. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
Background
While research on the efficacy of digital health applications (DiHA) is progressing, health economic evaluations (EEs) remain limited but are urgently needed to guide reimbursement and coverage decisions. Existing health policy frameworks frequently overlook cost-effectiveness considerations, and many studies presuppose cost savings without sufficient empirical validation. Although previous reviews have assessed digital health interventions more broadly, none has specifically focused on the cost-effectiveness of those intended for independent patient use.
Objective
This rapid review aims to summarize the current economic evidence and the methods used in health EEs, including modeling practices, and assess the quality of health economic studies on independently usable DiHA for patients.
Methods
A systematic search was conducted in 4 electronic databases (PubMed, Cochrane Library, EconBiz, and Web of Science), supplemented by both systematic and unsystematic hand searches. Studies were included on predefined inclusion criteria, considering only complete health EEs of DiHA intended for independent patient use. Data were narratively synthesized. Risk of bias (RoB) was assessed using the Cochrane risk of bias tool 2 (RoB 2), and methodological quality was evaluated using the Consensus on Health Economic Criteria (CHEC) checklist and the Consolidated Health Economic Evaluation Reporting Standards (CHEERS). The review adhered to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines for implementation and reporting.
Results
A total of 3841 results were identified. After screening the full texts of 82 publications, 7 studies were included in the final analysis. Four of the studies concluded that the app under review was cost-effective compared to the chosen control group. Most of the studies that provided economic evidence incorporated indirect costs and used a societal perspective. All studies used cost-utility analyses (n=7), with the majority based on randomized controlled trials (RCTs) (n=5), considering the health care payer perspective (n=3). Standard care was the most common comparator (n=5). Health outcomes were primarily measured using the EQ-5D (n=3) and condition-specific instruments (n=7). The incremental cost-effectiveness ratio, reported as costs per quality-adjusted life year, was the most frequently reported outcome (n=4). Overall, the quality of the EEs was rated positively using the CHEERS 2022 and CHEC checklists. However, more than half of the underlying RCTs exhibited a high RoB.
Conclusions
DiHA have the potential to be cost-effective, and evaluations of these are of increasing interest. However, health EE is not yet routinely applied in their assessment. Improved reporting of RCT outcomes and greater consistency in modeling practices are needed to support robust EEs in this domain, which could advance evidence-based decision-making and reimbursement policies. This review focused on studies of indication-specific apps, which may have excluded broader applications, highlighting opportunities for more comprehensive research as the field evolves.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Perfood GmbH, Lübeck, Germany.
- Department of Health Care Management, Faculty of Economics and Management, Technische Universität Berlin, Straße des 17. Juni 135, Berlin, 10623, Germany, 49 30 31428732.
- Private Institute for Applied Health Service Research (inav), Berlin, Germany.
- Institute of General Practice and Interprofessional Care, University Hospital Tübingen, Tübingen, Germany.
Zitieren
APA
Alber, V. A., Rödiger, H., Campione, A., Schiller, J., Burziwoda, D., & Henschke, C. (2025). An Overview on Methods, Evidence, and Study Quality of Health Economic Evaluation Studies for Independently Usable Digital Health Apps: Rapid Review. Journal of Medical Internet Research, 27, e68349-e68349. https://doi.org/10.2196/68349
Vancouver
Alber VA, Rödiger H, Campione A, Schiller J, Burziwoda D, Henschke C. An Overview on Methods, Evidence, and Study Quality of Health Economic Evaluation Studies for Independently Usable Digital Health Apps: Rapid Review. Journal of Medical Internet Research. 2025;27:e68349-e68349. doi:10.2196/68349
BibTeX
@article{Alber2025,
author = {Alber, Valerie Anne and Rödiger, Hendrikje and Campione, Alessandro and Schiller, Juliane and Burziwoda, Dominik and Henschke, Cornelia},
title = {An Overview on Methods, Evidence, and Study Quality of Health Economic Evaluation Studies for Independently Usable Digital Health Apps: Rapid Review},
journal = {Journal of Medical Internet Research},
year = {2025},
volume = {27},
pages = {e68349--e68349},
doi = {10.2196/68349}
}
EUVIMED